Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats

被引:93
作者
McCarthy, RJ
Kroin, JS
Tuman, KJ
Penn, RD
Ivankovich, AD
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Anesthesiol, Rush Med Coll, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Neurosurg, Rush Med Coll, Chicago, IL 60612 USA
关键词
D O I
10.1097/00000539-199804000-00028
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
N-methyl-D-aspartate (NMDA) antagonists, such as MK801, delay the development of morphine tolerance. Magnesium, a noncompetitive NMDA antagonist, reduces postoperative morphine requirements. The present study was designed to evaluate the effects of intrathecal co-administration of magnesium sulfate with morphine on antinociceptive potentiation, tolerance, and naloxone-induced withdrawal signs. Magnesium sulfate (40-60 mu g/h) co-administration for 7 days, similar to MK801 (10 nmol/h), prevented the decline in antinociceptive response compared with morphine (20 nmol/h). Magnesium sulfate (60 mu g/h) produced no antinociception, but co-infused with morphine (1 nmol/h), it resulted in potentiated antinociception compared with morphine throughout the 7-day period. Probe morphine doses after 7-day infusions demonstrated a significantly greater 50% effective dose value for morphine 1 nmol/h (109.7 nmol) compared with saline (10.9 nmol), magnesium sulfate 60 mu g/h (10.9 nmol), and magnesium sulfate 60 mu g/h plus morphine 1 nmol/h (11.2 nmol), which indicates that magnesium had delayed morphine tolerance. Morphine withdrawal signs after naloxone administration were not altered by the co-infusion of magnesium sulfate. Cerebrospinal fluid magnesium levels after intrathecal magnesium sulfate (60 mu g/h) for 2 days increased from 17.0 +/- 1.0 mu g/mL, to 41.4 +/- 23.6 mu g/mL, although serum levels were unchanged. This study demonstrates antinociceptive potentiation and delay in the development of morphine tolerance by the intrathecal coinfusion of magnesium sulfate and morphine in the rat. Implications: The addition of magnesium sulfate, an N-methyl-D-aspartate antagonist, to morphine in an intrathecal infusion provided better analgesia than morphine alone in normal rats. These results suggest that intrathecal administration of magnesium sulfate may be a useful adjunct to spinal morphine analgesia.
引用
收藏
页码:830 / 836
页数:7
相关论文
共 25 条
[1]   ELECTROPHYSIOLOGICAL STUDIES OF NMDA RECEPTORS [J].
ASCHER, P ;
NOWAK, L .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :284-288
[2]   SELECTIVE DEPRESSION OF EXCITATORY AMINO-ACID INDUCED DEPOLARIZATIONS BY MAGNESIUM-IONS IN ISOLATED SPINAL-CORD PREPARATIONS [J].
AULT, B ;
EVANS, RH ;
FRANCIS, AA ;
OAKES, DJ ;
WATKINS, JC .
JOURNAL OF PHYSIOLOGY-LONDON, 1980, 307 (OCT) :413-428
[3]   Spinal anaesthesia induced by intrathecal magnesium sulphate - An experimental study in a rat model [J].
Bahar, M ;
Chanimov, M ;
Grinspun, E ;
Koifman, I ;
Cohen, ML .
ANAESTHESIA, 1996, 51 (07) :627-633
[4]   THE NMDA RECEPTOR ANTAGONIST-MK-801 PREVENTS LONG-LASTING NONASSOCIATIVE MORPHINE-TOLERANCE IN THE RAT [J].
BENELIYAHU, S ;
MAREK, P ;
VACCARINO, AL ;
MOGIL, JS ;
STERNBERG, WF ;
LIEBESKIND, JC .
BRAIN RESEARCH, 1992, 575 (02) :304-308
[5]   EXCITATORY AMINO-ACIDS IN THE BRAIN - FOCUS ON NMDA RECEPTORS [J].
COTMAN, CW ;
IVERSEN, LL .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :263-265
[6]   Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat [J].
Dunbar, S ;
Yaksh, TL .
ANESTHESIOLOGY, 1996, 84 (05) :1177-1188
[7]  
FELSBY S, 1995, PAIN, V64, P283
[8]   FAILURE OF HIGH-DOSE INTRAVENOUS MAGNESIUM-SULFATE TO CONTROL MYOCLONIC STATUS EPILEPTICUS [J].
FISHER, RS ;
KAPLAN, PW ;
KRUMHOLZ, A ;
LESSER, RP ;
ROSEN, SA ;
WOLFF, MR .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (06) :537-544
[9]   THE SPECIFIC N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONIST MK-801 BLOCKS U-50,488, BUT NOT MORPHINE ANTINOCICEPTION [J].
KEST, B ;
MAREK, P ;
LIEBESKIND, JC .
BRAIN RESEARCH, 1992, 589 (01) :139-142
[10]   INTRATHECAL BACLOFEN DOWN-REGULATES GABA(B) RECEPTORS IN THE RAT SUBSTANTIA-GELATINOSA [J].
KROIN, JS ;
BIANCHI, GD ;
PENN, RD .
JOURNAL OF NEUROSURGERY, 1993, 79 (04) :544-549